Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

[Effect of autologous peripheral blood stem cell transplantation in 13 patients with AML1/ETO (+) acute myeloid leukemia].

Zhang QY, Huang WR, Dou LP, Deng AL, Fu L, Xu YH, Liu ZX, Li YH, Wang N, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):447-52. doi: 10.7534/j.issn.1009-2137.2014.02.033. Chinese.

PMID:
24763021
2.

[Long-term survival analysis in 89 adult patients with acute myeloid leukemia of fusion gene aml1/eto positive].

Fang YH, Liu HX, Tong CR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):750-5. Chinese.

PMID:
19549401
3.

[Monitoring AML1-ETO mRNA levels by real-time quantitative RT-PCR in t(8;21) acute myeloid leukemia patients after hematopoietic stem cell transplantation].

Wang ZD, Qin YZ, Liu YR, Xu LP, Liu DH, Liu KY, Huang XJ.

Zhonghua Xue Ye Xue Za Zhi. 2008 Oct;29(10):672-5. Chinese.

PMID:
19176061
4.

Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).

Zhang L, Li Q, Li W, Liu B, Wang Y, Lin D, Zhou C, Li C, Wang J, Mi Y.

Int J Hematol. 2013 Jun;97(6):786-92. doi: 10.1007/s12185-013-1344-6. Epub 2013 Apr 24.

PMID:
23613269
5.

Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.

Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T, Takenaka K, Mizuno S, Gondo H, Okamura T, Dohy H, Niho Y.

Blood. 1996 Jun 1;87(11):4789-96.

6.

Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia.

Yoo SJ, Chi HS, Jang S, Seo EJ, Seo JJ, Lee JH, Park HS, Park CJ.

Haematologica. 2005 Nov;90(11):1493-501.

7.

High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.

Gao X, Lin J, Gao L, Deng A, Lu X, Li Y, Wang L, Yu L.

PLoS One. 2015 Apr 10;10(4):e0124241. doi: 10.1371/journal.pone.0124241. eCollection 2015.

8.

[Detection of aml-1/eto fusion gene in patients with acute myeloid leukemia by real-time quantitative RT-PCR].

Jiang YM, Yuan H, Liu XY, Wang B, Li SJ, Wang N.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):17-22. Chinese.

PMID:
19236739
9.

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.

Viehmann S, Teigler-Schlegel A, Bruch J, Langebrake C, Reinhardt D, Harbott J.

Leukemia. 2003 Jun;17(6):1130-6.

PMID:
12764380
10.

Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia.

Zhang L, Cao Z, Ruan M, Zeng Q, Zhao L, Li Q, Zou Y, Wang J, Zhu X.

Pediatr Blood Cancer. 2014 Oct;61(10):1761-6. doi: 10.1002/pbc.25109. Epub 2014 Jun 11.

PMID:
24920269
11.

Significance of quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells from t(8;21) acute myelogenous leukemia.

Miyamoto T, Nagafuji K, Harada M, Niho Y.

Leuk Lymphoma. 1997 Mar;25(1-2):69-75. Review.

PMID:
9130615
12.

[Clinical features and prognosis of t (8; 21)/AML1-ETO-positive childhood acute myeloid leukemia].

Wu J, Zhang LP, Lu AD, Wang B, Cheng YF, Liu GL.

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Dec;13(12):931-5. Chinese.

PMID:
22172252
13.

Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.

Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AM, Knuutila S, Herzig GP, Bloomfield CD.

Blood. 1996 Sep 15;88(6):2183-91.

14.

AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.

Kusec R, Laczika K, Knöbl P, Friedl J, Greinix H, Kahls P, Linkesch W, Schwarzinger I, Mitterbauer G, Purtscher B, et al.

Leukemia. 1994 May;8(5):735-9.

PMID:
7514242
15.

AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.

Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L.

FEBS J. 2014 Feb;281(4):1123-31. doi: 10.1111/febs.12673. Epub 2014 Jan 10.

16.

[Clinical significance of detection of AML1/ETO fusion transcripts in childhood AML using real-time quantitative reverse transcription polymerase chain reaction].

Liu CF, Liu GL, Zhang LP, Cheng YF, Lu AD, Tian KG, Liu YR, Qin YZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):76-82. Chinese.

PMID:
15748440
17.

[Analysis of 21 children with acute non-lymphoid leukemia carrying AML1/ETO fusion gene].

Zhao W, Li ZG, Wu MY, Geng LZ, Shi HW, Zhang YH, Wu RH.

Zhonghua Er Ke Za Zhi. 2003 May;41(5):325-8. Chinese.

PMID:
14751048
18.

Is AML1/ETO gene expression a good prognostic factor in pediatric acute myeloblastic leukemia?

Sarper N, Ozbek U, Ağaoğlu L, Ozgen U, Eryilmaz E, Yalman N, Anak S, Devecioğlu O, Gedikoğlu G.

Pediatr Hematol Oncol. 2000 Oct-Nov;17(7):577-83.

PMID:
11033733
19.

Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.

Li Y, Wang H, Wang X, Jin W, Tan Y, Fang H, Chen S, Chen Z, Wang K.

Blood. 2016 Jan 14;127(2):233-42. doi: 10.1182/blood-2015-03-626671. Epub 2015 Nov 6.

20.

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.

Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, Zhang DE.

Nat Med. 2006 Aug;12(8):945-9. Epub 2006 Jul 30.

PMID:
16892037

Supplemental Content

Support Center